Michael Feigin
Assistant Professor
Department of Pharmacology & Therapeutics
Roswell Park Cancer Institute
United States of America
Biography
Dr. Michael Feigin works as an Assistant Professor of Oncology in the Department of Pharmacology & Therapeutics at Roswell Park Cancer Institute. His research interest includes: G-protein coupled receptor signaling, Noncoding mutations in cancer, Pancreatic cancer, Breast cancer, Melanoma. He has received his PhD from Stony Brook University in Molecular and Cellular Pharmacology
Research Interest
G-protein coupled receptor signaling, Noncoding mutations in cancer, Pancreatic cancer, Breast cancer, Melanoma
Publications
-
Feigin ME, (2013) Harnessing the genome for characterization of GPCRs in cancer pathogenesis. (Review) FEBS Journal 280: 4729-4738
-
Feigin ME, Akshinthala SD, Araki K, Rosenberg AZ, Muthuswamy LB, et al. (2014) Mislocalization of the polarity protein Scribble promotes mammary tumorigenesis and is associated with basal breast cancer. Cancer Research 74: 3180-3194
-
Feigin ME, Xue B, Hammell MC, Muthuswamy SK, (2-14) G-protein-coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion. PNAS 111: 4191-4196
